Status of research and development of vaccines for Streptococcus pyogenes

Area of Science:

• Microbiology
• Vaccinology
• Infectious Diseases

Background:

• * Streptococcus pyogenes is a significant global pathogen responsible for substantial illness and death.
• * Rheumatic heart disease and invasive infections caused by this bacterium are prevalent in low and middle-income countries.

Purpose of the Study:

• * To highlight the challenges and barriers in developing vaccines against Streptococcus pyogenes.
• * To emphasize the need for a strategic roadmap for current and future vaccine candidates.

Main Methods:

• * Review of existing literature on Streptococcus pyogenes pathogenesis and vaccine development.
• * Analysis of M protein as a key virulence factor and vaccine target.
• * Examination of barriers impeding vaccine progress.

Main Results:

• * Promising vaccine candidates, particularly those targeting the M protein, have been identified.
• * Significant obstacles hinder the progression of these vaccines, classifying them as 'impeded vaccines'.
• * Substantial collaborative effort is required to advance candidates through Phase III trials.

Conclusions:

• * Streptococcus pyogenes vaccine development requires a concerted effort from all stakeholders.
• * A clear roadmap is essential to guide the future development of both existing and novel vaccine candidates.
• * Overcoming current barriers is critical for reducing the global burden of Streptococcus pyogenes infections.